Tarsons Products [TARSONS] vs Centennial Surgical [CSURGSU] Detailed Stock Comparison
Tarsons Products
NSE
Loading...
Centennial Surgical
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Tarsons Products wins in 11 metrics, Centennial Surgical wins in 8 metrics, with 0 ties. Tarsons Products appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Tarsons Products | Centennial Surgical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 63.57 | 2,482.50 | Tarsons Products |
| Price-to-Book Ratio | 2.78 | 1.87 | Centennial Surgical |
| Debt-to-Equity Ratio | 53.82 | 108.97 | Tarsons Products |
| PEG Ratio | -1.16 | -21.89 | Centennial Surgical |
| EV/EBITDA | 18.41 | 16.74 | Centennial Surgical |
| Profit Margin (TTM) | 6.90% | -3.42% | Tarsons Products |
| Operating Margin (TTM) | 5.22% | 2.14% | Tarsons Products |
| EBITDA Margin (TTM) | 5.22% | 2.14% | Tarsons Products |
| Return on Equity | 4.72% | -4.76% | Tarsons Products |
| Return on Assets (TTM) | 2.76% | -1.73% | Tarsons Products |
| Free Cash Flow (TTM) | $-374.69M | $56.05M | Centennial Surgical |
| Dividend Yield | 0.53% | N/A | N/A |
| 1-Year Return | -28.78% | 49.22% | Centennial Surgical |
| Price-to-Sales Ratio (TTM) | 4.40 | 1.09 | Centennial Surgical |
| Enterprise Value | $20.91B | $909.18M | Tarsons Products |
| EV/Revenue Ratio | 5.24 | 1.73 | Centennial Surgical |
| Gross Profit Margin (TTM) | 67.93% | 66.56% | Tarsons Products |
| Revenue per Share (TTM) | $75 | $145 | Centennial Surgical |
| Earnings per Share (Diluted) | $5.19 | $-4.94 | Tarsons Products |
| Beta (Stock Volatility) | 0.11 | 0.49 | Tarsons Products |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Tarsons Products vs Centennial Surgical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Tarsons Products | -0.15% | -3.72% | -14.71% | -13.52% | 9.94% | -19.25% |
| Centennial Surgical | 3.61% | -1.25% | 0.64% | 18.76% | 72.53% | 16.14% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Tarsons Products | -28.78% | -57.67% | -59.98% | -59.98% | -59.98% | -59.98% |
| Centennial Surgical | 49.22% | 194.41% | 298.86% | 220.06% | 7,493.75% | 14,942.86% |
Performance & Financial Health Analysis: Tarsons Products vs Centennial Surgical
| Metric | TARSONS | CSURGSU |
|---|---|---|
| Market Information | ||
| Market Cap | ₹17.56B | ₹576.25M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 101,601 | 50 |
| 90 Day Avg. Volume | 56,632 | 171 |
| Last Close | ₹327.50 | ₹157.95 |
| 52 Week Range | ₹280.00 - ₹491.80 | ₹82.15 - ₹169.50 |
| % from 52W High | -33.41% | -6.81% |
| All-Time High | ₹924.90 (Nov 29, 2021) | ₹169.50 (Dec 16, 2024) |
| % from All-Time High | -64.59% | -6.81% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | -0.06% |
| Quarterly Earnings Growth | -0.56% | -0.06% |
| Financial Health | ||
| Profit Margin (TTM) | 0.07% | -0.03% |
| Operating Margin (TTM) | 0.05% | 0.02% |
| Return on Equity (TTM) | 0.05% | -0.05% |
| Debt to Equity (MRQ) | 53.82 | 108.97 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹118.59 | ₹84.30 |
| Cash per Share (MRQ) | ₹4.89 | ₹0.60 |
| Operating Cash Flow (TTM) | ₹571.91M | ₹36.99M |
| Levered Free Cash Flow (TTM) | ₹297.70M | ₹-14,636,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.53% | N/A |
| Last 12-Month Dividend | ₹2.00 | N/A |
Valuation & Enterprise Metrics Analysis: Tarsons Products vs Centennial Surgical
| Metric | TARSONS | CSURGSU |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 63.57 | 2,482.50 |
| Forward P/E | 26.61 | N/A |
| PEG Ratio | -1.16 | -21.89 |
| Price to Sales (TTM) | 4.40 | 1.09 |
| Price to Book (MRQ) | 2.78 | 1.87 |
| Market Capitalization | ||
| Market Capitalization | ₹17.56B | ₹576.25M |
| Enterprise Value | ₹20.91B | ₹909.18M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.24 | 1.73 |
| Enterprise to EBITDA | 18.41 | 16.74 |
| Risk & Other Metrics | ||
| Beta | 0.11 | 0.49 |
| Book Value per Share (MRQ) | ₹118.59 | ₹84.30 |
Financial Statements Comparison: Tarsons Products vs Centennial Surgical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TARSONS | CSURGSU |
|---|---|---|
| Revenue/Sales | ₹913.64M | ₹133.08M |
| Cost of Goods Sold | ₹293.05M | ₹35.40M |
| Gross Profit | ₹620.59M | ₹97.68M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹47.67M | ₹8.05M |
| EBITDA | ₹280.39M | ₹21.17M |
| Pre-Tax Income | ₹30.32M | ₹-13.38M |
| Income Tax | ₹12.49M | ₹-1.54M |
| Net Income (Profit) | ₹17.83M | ₹-11.84M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TARSONS | CSURGSU |
|---|---|---|
| Cash & Equivalents | ₹251.31M | ₹2.20M |
| Total Current Assets | ₹2.43B | ₹629.64M |
| Total Current Liabilities | ₹1.76B | ₹318.30M |
| Long-Term Debt | ₹2.12B | N/A |
| Total Shareholders Equity | ₹6.30B | ₹307.55M |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹4.72B | ₹199.83M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TARSONS | CSURGSU |
|---|---|---|
| Operating Cash Flow | ₹100.02M | N/A |
| Capital Expenditures | ₹-279.63M | N/A |
| Free Cash Flow | ₹-231.27M | N/A |
| Debt Repayment | ₹-754.90M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | TARSONS | CSURGSU |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 101,601 | 50 |
| Average Daily Volume (90 Day) | 56,632 | 171 |
| Shares Outstanding | 53.21M | 3.65M |
| Float Shares | 13.20M | 615,942 |
| % Held by Insiders | 0.75% | 0.81% |
| % Held by Institutions | 0.08% | 0.00% |
Dividend Analysis & Yield Comparison: Tarsons Products vs Centennial Surgical
| Metric | TARSONS | CSURGSU |
|---|---|---|
| Last 12-Month Dividend | ₹2.00 | N/A |
| Last 12-Month Dividend Yield | 0.53% | N/A |
| 3-Year Avg Annual Dividend | ₹0.67 | N/A |
| 3-Year Avg Dividend Yield | 0.46% | N/A |
| 3-Year Total Dividends | ₹2.00 | N/A |
| Ex-Dividend Date | Sep 20, 2024 | N/A |